Amy Mahery
Director/Board Member bei CNS PHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2024
Profil
Amy Mahery is currently an Independent Director at CNS Pharmaceuticals, Inc. and a Chief Commercial Officer at Roivant Sciences Ltd.
Previously, she worked as a Senior Vice President at EMD Serono, Inc. Ms. Mahery completed her undergraduate degree at Trinity College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
08.04.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Amy Mahery
Unternehmen | Position | Beginn |
---|---|---|
ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01.08.2022 |
CNS PHARMACEUTICALS, INC. | Director/Board Member | 18.01.2024 |
Ehemalige bekannte Positionen von Amy Mahery
Unternehmen | Position | Ende |
---|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.07.2022 |
Ausbildung von Amy Mahery
Trinity College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ROIVANT SCIENCES LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
CNS Pharmaceuticals, Inc. |